Nvidia and AMD are back in the China game — at a price. The chipmakers agreed to remit 15% of revenue from advanced AI chip sales in China to the U.S. government in exchange for export licenses tied to Nvidia’s H20 and AMD’s MI308 accelerators. The arrangement, confirmed by multiple outlets and described as unprecedented even by trade veterans, puts a hard number on the cost of access to the world’s second-biggest AI market. “They had no choice,” said Wedbush’s Dan Ives on Bloomberg Surveillance, calling it a “high-stakes poker” hand the industry had to play to keep China demand in their models.
Investors pushed both stocks into focus as traders weighed the math: 85% of China revenue is better than zero, particularly after earlier curbs cratered shipments and left Nvidia admitting to a multibillion-dollar dent from the H20 freeze. The Trump administration’s dealmaking reflects a transactional export-control regime — not a blanket ban, but a meter running on every sale. It’s a policy turn that tries to balance national security goals with the reality that U.S. chip firms need China’s volume to sustain an AI capex supercycle and fend off local competitors.
The mechanics are simple and brutal. A 15% skim off the top functions like a dedicated revenue royalty layered on top of ordinary taxes. For Nvidia and AMD, the gross margin math still favors selling into China if permitted: AI accelerators remain capacity constrained and carry premium pricing, and the marginal unit sold into a previously closed market spreads fixed costs and improves utilization. But the revenue share dilutes both reported revenue and operating leverage. Expect CFOs to re-baseline Street expectations, segment China’s impact in guidance, and emphasize that the reinstated volumes are accretive relative to a sales freeze even if headline margins tick down.
How much it moves the earnings needle hinges on velocity and mix. If Chinese hyperscalers and big tech customers are cleared to buy H20 and MI308 at meaningful scale, unit volume can overwhelm the 15% toll. If licenses cap performance or volume, the royalty becomes a persistent drag with less offset. One variable: pricing power. Nvidia and AMD could attempt to pass through some of the 15% by lifting invoice prices to China buyers who are already paying premiums to secure inventory. The risk is obvious: push pricing too far and you accelerate substitution by domestic alternatives; don’t push at all and you eat the entire levy. Given the scarcity of frontier compute, suppliers likely test modest pass-through while protecting long-term relationships.
This is new ground for Washington. Export controls have historically blocked or conditioned shipments, not captured a slice of corporate revenue. A mandated revenue share looks and feels like a bespoke tariff administered at the firm level — and it raises questions about where this ends. Could rates vary by product tier or buyer? Will similar terms get imposed on other strategic goods, from semiconductor tools to quantum hardware? The business community can live with rules; it struggles with rule volatility. Policy risk is now embedded directly in the P&L of two of the market’s most important companies.
Inside the companies, lawyers and accountants are going to work. How the levy is recognized — contra-revenue, cost of sales, or a separate line item — matters for reported margins, tax deductibility, and cash flow. Enforcement demands granular audit trails of shipments, end users, and revenue recognition. The U.S. government will need verification systems and consequences for slippage, and boards will demand clarity on what triggers license suspensions or rate changes. The policy lever is powerful precisely because it’s adjustable. Investors should expect a standing risk factor in filings that future administrations could tighten, loosen, or broaden the program with little notice.
Beijing’s next move is a wild card. Accepting the terms keeps the taps open for state-backed clouds and consumer-internet giants that need frontier GPUs now, not in three years. Retaliation — via countersanctions, procurement directives favoring domestic chips, or pressure on U.S. firms with onshore exposure — would escalate a fragile equilibrium. In practice, China’s AI leaders have pursued a dual-track strategy: buy as many compliant U.S. parts as they can while scaling domestic designs from players like Huawei and a cohort of smaller GPU startups. The resumed availability of H20 and MI308 buys time for domestic stacks to mature, but also locks in exposure to U.S. policy. Everyone in the value chain is hedging.
There’s also optics. Chinese buyers paying a U.S. government rake-off on each chip sets a politically awkward precedent. But the alternative is years of diminished compute capacity. In AI, compute is strategy. That’s why the initial reaction from industry voices is pragmatic: take the deal, secure supply, push on domestic R&D, and revisit if the rate ratchets higher or performance caps bite.
For Nvidia and AMD, clarity beats limbo. Sales pipelines can be reactivated, distributors can forecast, and foundry partners can plan capacity. Expect constrained allocations and firm pricing as suppliers prioritize the highest-value, highest-visibility customers while rationing to avoid stockpiles that invite policy backlash. U.S. hyperscalers and marquee AI startups likely remain at the front of the line; China volumes return, but not at the expense of core customers. That supply discipline supports pricing even with the revenue share.
Downstream, server makers and integrators exposed to China AI buildouts get a reprieve. Upstream, foundries and packaging houses — chiefly TSMC and advanced OSATs — benefit from steadier orders. The competitive gap doesn’t close overnight. Nvidia retains the software ecosystem moat; AMD keeps pressing price-performance angles. Domestic Chinese chips will keep improving but are likely to lag top-tier U.S. parts for a while. The policy variable dominates the near-term narrative.
Call it a tariff by another name or a license royalty; either way, the arrangement monetizes national security policy. That invites copycats. Other governments may seek similar mechanisms, either to align with U.S. controls or to extract rent from strategic sectors. For markets, the key is predictability. Rate stability and clear renewal timelines would turn today’s shock into a model that analysts can underwrite. Capricious adjustments will keep a volatility premium pinned to these stocks, particularly around election and summit calendars.
Voices in the market are split. Some view the setup as “bizarre” and precedent-setting in the worst way, a slippery slope that could migrate to cloud services, EDA software, or even EV components. Others see a hard-nosed compromise that averts a de facto decoupling and preserves U.S. leadership by keeping design houses funded and global. Both perspectives can be true. What matters to shareholders is that volume flows, and that the policy overhang is not existential.
Timelines on license processing and first shipments under the new regime will be the first tell. Then watch for disclosures on revenue recognition and any breakouts of China exposure in management commentary. Price realization in China versus the rest of world will hint at pass-through success. On the policy side, monitor for chatter about expanding the revenue-share model to semiconductor tools or to more advanced chip SKUs, and for any Chinese administrative guidance that tilts procurement toward domestic alternatives.
For now, the market has an answer to a question that has shadowed AI’s hottest trade for a year: can the leaders sell into China without blowing up Washington? The answer is yes, at 85 cents on the dollar, with a regulator looking over their shoulder. It’s not clean. It may not be durable. But it resets the board and keeps the AI capex flywheel turning, which is exactly why these companies took the deal.
